|
HS Code |
120196 |
| Productname | Ethyl 4-tert-butoxyacetoacetate |
| Casnumber | 65699-43-2 |
| Molecularformula | C12H22O5 |
| Molecularweight | 246.30 |
| Appearance | Colorless to pale yellow liquid |
| Boilingpoint | 127-130 °C at 4 mmHg |
| Density | 1.045 g/cm3 at 25 °C |
| Refractiveindex | 1.422-1.426 at 20 °C |
| Flashpoint | 113 °C |
| Purity | Typically ≥98% |
| Solubility | Soluble in organic solvents such as ethanol and ether |
As an accredited Ethyl 4-tert-butoxyacetoacetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ethyl 4-tert-butoxyacetoacetate is packaged in a 100g amber glass bottle with a secure screw cap and clear hazard labeling. |
| Container Loading (20′ FCL) | **Container Loading (20′ FCL):** Ethyl 4-tert-butoxyacetoacetate typically loads 16-18 metric tons per 20′ FCL in HDPE drums or steel drums. |
| Shipping | Ethyl 4-tert-butoxyacetoacetate is typically shipped in sealed, chemical-resistant containers to prevent contamination and degradation. During transit, it should be kept away from strong oxidizing agents and stored at a cool, dry location. Standard shipping regulations for non-hazardous organic chemicals apply; always follow local and international chemical transport guidelines. |
| Storage | Ethyl 4-tert-butoxyacetoacetate should be stored in a tightly closed container in a cool, dry, well-ventilated area, away from sources of ignition, heat, and incompatible substances such as strong oxidizing agents. Protect from moisture and direct sunlight. Use appropriate safety measures, including gloves and eye protection, when handling. Label the container clearly and keep it away from food and drink. |
| Shelf Life | **Ethyl 4-tert-butoxyacetoacetate** typically has a shelf life of 12–24 months when stored tightly sealed, cool, and protected from moisture. |
Competitive Ethyl 4-tert-butoxyacetoacetate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Ethyl 4-tert-butoxyacetoacetate may seem like another name on a long list of specialty esters, but it offers a toolkit that sets it apart in day-to-day manufacturing. In our experience providing this compound in industrial volume, the genuine value lies not just in its chemical structure but in how reliably it fits modern synthetic needs. Our facility has been running continuous batches for years, working closely with downstream users who require solid predictability in each shipment. We see this compound in action far beyond laboratories—it shows up in large reaction kettles, feeding into the daily pulse of pharmaceutical and agrochemical production.
In our production line, we offer Ethyl 4-tert-butoxyacetoacetate with careful adjustment of spec markers. These include high-purity grades targeted toward demanding pharmaceutical pathways as well as robust, standardized lots for less sensitive agrochemical synthesis. Typical GC purity surpasses 99 percent for pharmaceutical customers, with water measured below 0.1 percent to keep downstream reactions sharp and avoid side-product headaches. Every drum packed under our line passes both FTIR confirmation and a hands-on check for clarity, ensuring the absence of cloudiness or unexpected coloration. As a manufacturer, we pay attention not just to the average values but also to the tightness of those specs—nothing erodes efficiency faster than inconsistent intermediate quality.
Shipping formats range from 5-liter sample cans to full pallet drums, built to support both R&D benchwork and process-scale reactors. We’ve tailored our logistics and QA systems so that different lots retain the same fingerprint; process engineers expect exactly the same response in their syntheses, batch after batch.
The story of Ethyl 4-tert-butoxyacetoacetate speaks to daily process gains, not just catalog entries. The tert-butoxy group provides a balance between steric protection and reactivity. Unlike more exposed acetoacetate esters that sometimes fall victim to unwanted side reactions, this molecule shields the β-carbon, putting brakes on uncontrolled condensations and reducing risks linked with unstable intermediates. It remains compatible with typical acetoacetic ester reactions—alkylations, Michael additions, and ring-forming steps—while giving operators more leeway in temperature and pH ranges.
In comparison, running similar procedures with traditional ethyl acetoacetate can lead to byproduct formation or loss of selectivity, especially when process variables drift or raw materials vary. Users in our network have found that swapping in Ethyl 4-tert-butoxyacetoacetate reduces cycle time spent on purification, solvent washes, and column loading. We’ve heard direct feedback: less downtime chasing purity, fewer distillation headaches, and broader compatibility with composite formulations.
Our partners in the pharmaceutical sector lean on this intermediate for building substituted pyridines, pyrazoles, and various heterocycle scaffolds. The tert-butoxy moiety provides strategic protection, enabling clean deprotection at later stages, which speeds up multi-step syntheses. In crowded process spaces, this selectivity matters; the savings compound over time, not just per batch but across a product’s entire lifecycle.
Agrochemical formulators value the lower volatility and thermal stability compared to traditional beta-keto esters. These properties support safe scale-up, allowing larger batch sizes in plant reactors. Environmental and safety demands continue to climb, and process designers appreciate a compound that sidesteps runaway exotherms or problematic emissions. We often discuss with plant managers how the slight bulk added by the tert-butoxy group translates to smoother control during alkylation and condensation procedures.
Many chemists originally relied on ethyl acetoacetate or methyl acetoacetate, which are broadly available and have long process histories. Over time, as yields needed to stretch and selectivity gained importance, demand shifted toward more substituted esters. Ethyl 4-tert-butoxyacetoacetate demonstrates reduced reactivity at the β-carbon, specifically designed to prevent premature reactions. It stands out when systems require delayed activation or selective deprotection—extending the shelf life of blends and improving the purity of follow-up products.
During process optimization conversations, we note a marked reduction in impurity loads and waste volumes when substituting this compound. The need for excessive workup, repeated washes, and column reprocessing goes down, which our plant teams track as tangible cost savings. Storage managers notice fewer resin fouling issues in filtration equipment and lower solvent loads returned as hazardous waste. In direct comparison against plain acetoacetates, our operators enjoy safer, less volatile drum handling, especially in hotter climates.
Producing Ethyl 4-tert-butoxyacetoacetate at scale means confronting practical realities. Raw material quality swings, variable reactor conditions, and shipping exposure all shape the final outcome. Our technical team maintains a rigorous audit trail tracing every batch from starting ethanol and tert-butyl acetate through to finished material. Each production cycle brings lessons. On one occasion, small fluctuations in raw tert-butyl acetate purity led to downstream issues with color and odor that took weeks to correct. We responded by moving to dual-source raw supply and implementing additional pre-integration checks, embedding lessons learned directly into our process flow.
Our staff includes process engineers, organic synthetic chemists, and logistics coordinators—many with years on the same shop floor. Open dialogue with end users pushes us to refine specifications, tighten traceability, and tune protocol for real plant conditions rather than lab-bench ideals. When a pharmaceutical synthesis missed a conversion benchmark due to a subtle contaminant, our teams went back through months of logs, isolated the problem at a specific purification wash step, then updated tank cleaning routines. These iterative improvements make a difference for continuous end users who stake millions of dollars per year on uninterrupted output.
With decades in the industry, our ears have caught a full range of issues: delayed supply, unexpected impurities, traceability headaches, and difficulties scaling up from pilot to kilo or ton quantities. Each story shapes the way we approach this and every other product, from scheduling QA checkpoints to training warehouse teams on moisture prevention during drum transfers.
Drum packaging might seem routine, but improper capping, rushed loading, or insufficiently dried shipping containers can cause measurable moisture ingress. Experience tells us that even small changes in moisture can alter reactivity—not always at once, but sometimes in slow quality drift, undermining what looks fine on the paperwork. To prevent this, our loading teams monitor ambient humidity and double-check desiccant protocols. We have had shipments inspected independently by major pharma clients, and post-delivery testing has repeatedly matched our own measurements, giving mutual confidence in ongoing supply relationships.
New customers often ask about handling properties in full-scale reactors where line cleaning and residual contamination become ongoing concerns. The lower volatility and resistance to hydrolysis help plant maintenance teams keep lines running between cleaning schedules, avoiding product carryover between campaigns. We encourage feedback from plant chemists on unexpected residues, then adjust our recommended cleaning solvents and drying targets accordingly.
Manufacturing intermediates with complex protecting groups, like Ethyl 4-tert-butoxyacetoacetate, requires constant attention to waste minimization. Increased environmental regulation has changed the ground rules; standard waste incineration no longer gets a green light for all byproducts. We redesigned recovery and recycling processes so that spent solvents and reactant fractions move through staged purification rather than single-stage disposal. Several projects on our shop floor now recover and purify side streams, routing back tert-butanol and ethanol to new reactions. Wastewater streams undergo in-line treatment before entering broader site effluent—a direct response to stricter discharge permits.
Our management monitors input-versus-yield and waste intensity on every batch. Each swing, whether caused by raw material changes or seasonal climate effects, gets logged and analyzed for process drift. Over time, we have seen the return on investment in solvent recovery buff up not just company environmental credentials, but also the bottom line. Achieving consistent product quality while keeping byproduct metrics below regional thresholds happens by design, not by chance.
Direct conversations with users have driven unforeseen product changes. In one instance, a large volume pharma customer flagged inconsistent performance in a multi-step synthesis involving a ring closure. We reviewed reactor logs, traced slight increases in peroxide formation back to a specific storage tank, and modified both inhibitor dosing in supply drums and nitrogen headspace protocols. The fix restored expected performance downstream, and we rolled out new stability guidelines to all shipments. Such insights often only come from open feedback loops—there’s no substitute for practical operating experience on both ends of the supply chain.
We work with both long-term partners and first-time buyers, pushing updated protocols based on aggregate feedback rather than just internal QA checklists. Occasionally, requests for custom packaging, special dilution blends, or non-standard labeling spur investment in specialized filling lines and secondary containment. Such flexibility pays off: smoother plant workflows and lower error rates ripple upstream and downstream, reducing stoppages and unplanned downtime.
Safe, reliable handling keeps plants moving. As manufacturers, we keep safety at the center of every drum shipment. Ethyl 4-tert-butoxyacetoacetate behaves more docilely in storage than many similar acetoacetate esters, but that does not make it maintenance free. Our facilities store drums in climate-controlled areas, away from oxidizer risks and strong acids or bases, reducing the potential for runaway decomposition. Forklift operators receive specific training to prevent punctures or cap loosening during stacking and transfer.
Customers often ask about shelf life and long-term stability. We have tracked product held across both production and distribution centers under typical warehouse humidity and temperature. Over a two-year holding period, drums sealed under nitrogen maintained both color and purity benchmarks, with no measurable increase in side products. This gives procurement teams room when synchronizing plant maintenance shutdowns and ongoing campaign schedules.
In our experience, the main variable affecting shelf life remains container integrity. Drum batches left open or with compromised seals can pick up both moisture and contaminants, leading not just to off-odor but measurable GC drift in both product and byproduct loads. To combat this, we use batch-specific QC tagging, regular cap inspection checks, and stringent supplier criteria for metal and plastic drum stock. All empty drums get returned and scanned for any sign of corrosion or wall thinning before next use.
Modern process chemistry often faces margin pressure and regulatory overhead. Choosing intermediates that streamline the pathway matters both for product quality and operational efficiency. Ethyl 4-tert-butoxyacetoacetate strikes a sweet spot between robust protecting group chemistry and day-to-day handling convenience. Our production teams see fewer procedure deviations when plants use this intermediate versus less protected esters.
Many downstream chemists report marked improvement in overall process performance—higher yields, shorter purification, and reduced downtime—after transitioning to this compound. Formulation teams working on next-generation acts for crop protection have flagged improved stability without added complexity in manufacturing workflows. This consistency breeds confidence, allowing research chemists and production managers to focus on process development and market delivery rather than troubleshooting avoidable bottlenecks.
Each improvement made at the manufacturing stage propagates benefits through the supply chain, making life easier for QA teams, warehouse managers, and line operators. These advantages go beyond theory—they stem from the real-world practice of pushing drums out the factory door and seeing them thrive in the chaos of global plant operations.
The landscape of chemical synthesis keeps shifting, driven by tightening environmental regulation, evolving therapeutic needs, and new material demands. Our approach to Ethyl 4-tert-butoxyacetoacetate places emphasis on agility. We engage product managers and plant engineers months before major campaign changes, review process candidly, and adapt output volumes and packaging types rather than waiting for bottlenecks to develop.
Continuous improvement efforts have driven us to explore cleaner synthetic routes and higher atom efficiency, shortening batch times and lowering the overall environmental footprint. We routinely reassess upstream raw material supply, look for renewable alternatives, and keep the door open to customer-initiated process audits.
Our endgame stays unchanged: supply a high-reliability intermediate, rooted in practical reality, shaped by both our own experience as manufacturers and the lived needs of those who rely on every drum, tote, and batch to work the same—every time. This perspective guides our standing commitment to safe handling, transparent quality protocols, and a sharp focus on the outcomes that matter most in daily industrial synthesis.